Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardioprotection for Duchenne's muscular dystrophy.

Y Ishikawa1, J R Bach, R Minami

  • 1Department of Pediatrics, National Yakumo Hospital, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newwark, NJ, USA.

American Heart Journal
|April 30, 1999
PubMed
Summary

Neuroendocrine monitoring aids in early dilated cardiomyopathy (DCM) diagnosis in Duchenne muscular dystrophy (DMD). Combination therapy with ACE inhibitors (ACEI) and beta-blockers improves cardiac function and reduces neuroendocrine markers in DMD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration.

Pulmonology·2021
Same author

Improvement in multipass Thomson scattering system comprising laser amplification system developed in GAMMA 10/PDX.

The Review of scientific instruments·2021
Same author

Noninvasive ventilatory support in morbid obesity.

Pulmonology·2021
Same author

Daytime non-invasive ventilatory support via intermittent abdominal pressure for a patient with Pompe disease.

Pulmonology·2020
Same author

Development of a laser amplification system for the multi-pass Thomson scattering system for GAMMA 10/PDX.

The Review of scientific instruments·2018
Same author

Noninvasive ventilatory support to reverse weight loss in Duchenne muscular dystrophy: A case series.

Pulmonology·2018

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Duchenne muscular dystrophy (DMD) is associated with an increased risk of dilated cardiomyopathy (DCM).
  • Early diagnosis and management of DCM in DMD patients are crucial for improving outcomes.
  • Neuroendocrine activation plays a role in the pathophysiology of heart failure.

Purpose of the Study:

  • To evaluate neuroendocrine monitoring for timely DCM diagnosis in DMD.
  • To assess the impact of ACE inhibitors (ACEI) and beta-blockers on neuroendocrine levels, cardiac function, and mortality in DMD patients with DCM.

Main Methods:

  • Eighty-five DMD patients underwent annual cardiac monitoring, including neuroendocrine screening.
  • Eleven patients with elevated neuroendocrine levels developed DCM symptoms and were treated with ACEI and beta-blockers.

Related Experiment Videos

  • Treatment duration ranged from 7 to 62 months.

    • Main Results:

    • Combination therapy with ACEI and beta-blockers improved heart failure symptoms and signs in all 11 patients.
    • Significant reductions were observed in atrial natriuretic peptide (ANP), brain natriuretic peptide, and norepinephrine levels.
    • Left ventricular ejection fraction (LVEF) increased significantly, while left ventricular diastolic diameter (LVDd) showed a non-significant trend towards reduction.

    Conclusions:

    • Neuroendocrine monitoring can aid in the early diagnosis of DCM in DMD.
    • Combination therapy with ACEI and beta-blockers effectively reduces neuroendocrine activation and improves cardiac function in DMD patients.
    • This therapeutic approach can reverse symptoms of congestive heart failure in DMD patients.